Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02120417
Brief Title: A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer

First Submitted : April 18, 2014
First Submitted that Met QC Criteria : April 18, 2014
First Posted : April 22, 2014 (Estimate)

Results First Submitted : February 6, 2017
Results First Submitted that Met QC Criteria : July 10, 2017
Results First Posted : July 12, 2017

Last Update Submitted that Met QC Criteria : January 15, 2018
Last Update Posted : February 13, 2018